Adaptimmune Therapeutics PLC reports results for the quarter ended in December - Earnings Summary

Adaptimmune Therapeutics

06/03/2024 14:42

* Adaptimmune Therapeutics PLC  ADAP.OQ  reported a
quarterly
adjusted loss of 24 cents​​ per share for the quarter ended in
December, lower than the same quarter last year, when the
company reported EPS of -18 cents.  The mean expectation of
five analysts for the quarter was for a loss of 10 cents per
share. Wall Street expected results to range from -17 cents
tozero cents per share.
    * Revenue fell 97.9% to $231.00 thousand from a year ago;
analysts
expected $20.47 million. 
    * Adaptimmune Therapeutics PLC's reported EPS for the
quarter was
a loss of 24 cents​.
    * The company reported a quarterly loss of $47.92 million.
    * Adaptimmune Therapeutics PLC shares had risen by 84.1%
this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "hold"

Wall Street's median 12-month price target for Adaptimmune
Therapeutics PLC is $2.00 
This summary was machine generated from LSEG data March 6 at
02:40 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.10          -0.24          Missed
 Sep. 30 2023      -0.14          -0.20          Missed
 Jun. 30 2023      -0.13          -0.23          Missed
 Mar. 31 2023      -0.15          0.01           Beat